Hongwei T. Wang

Tianjin Key Laboratory Of Digestive Cancer, Key Laboratory Of Cancer Prevention And Therapy
Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Development and validation of a multiparametric magnetic resonance imaging-based nomogram for predicting feasibility of sphincter-preserving surgery in mid-low rectal cancer.

Development and validation of a multiparametric magnetic resonance imaging-based nomogram for predicting feasibility of sphincter-preserving surgery in mid-low rectal cancer.

Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu

Published: January 09, 2026

Retraction Note: BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis.

Retraction Note: BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis.

Journal: Signal transduction and targeted therapy

Published: January 03, 2026

Identifying occult high-risk features and stratified management strategies following curative resection for ampullary adenocarcinoma.

Identifying occult high-risk features and stratified management strategies following curative resection for ampullary adenocarcinoma.

Journal: Cancer biology & medicine

Published: October 17, 2025

CLT-003 exerts anti-tumor activity in pancreatic cancer by blocking the PI3K/AKT/HIF-1α pathway.

CLT-003 exerts anti-tumor activity in pancreatic cancer by blocking the PI3K/AKT/HIF-1α pathway.

Journal: Cancer biology & medicine

Published: September 30, 2025

Integrated pretreatment stratification system for pancreatic cancer: combining anatomical resectability and tumor biological parameters.

Integrated pretreatment stratification system for pancreatic cancer: combining anatomical resectability and tumor biological parameters.

Journal: Cancer biology & medicine

Published: September 27, 2025

Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Mediated Metabolic-Epigenetic Rewiring.

Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Mediated Metabolic-Epigenetic Rewiring.

Journal: Cancer discovery

Published: September 18, 2025

Comparison of a Specialized Large Language Model with GPT-4o for CT and MRI Radiology Report Summarization.

Comparison of a Specialized Large Language Model with GPT-4o for CT and MRI Radiology Report Summarization.

Journal: Radiology

Published: September 02, 2025

Corrigendum to "A novel platinum(IV) prodrug, gramine-Pt(IV) enhances chemoimmunotherapy by activating cGAS-STING and modulating TGF-β-MHC-I axis" [Drug Resist. Updates 81 (2025) 101252].

Corrigendum to "A novel platinum(IV) prodrug, gramine-Pt(IV) enhances chemoimmunotherapy by activating cGAS-STING and modulating TGF-β-MHC-I axis" [Drug Resist. Updates 81 (2025) 101252].

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: June 14, 2025

CAF-derived PAI-1 serves as an EGFR ligand and fuels KRAS-mutant pancreatic cancer.

CAF-derived PAI-1 serves as an EGFR ligand and fuels KRAS-mutant pancreatic cancer.

Journal: Nature communications

Published: May 29, 2025

Trogocytosis-orchestrated CLDN18.2-"dressed" CD8+ T cells drive pancreatic cancer progression via glucose metabolic reprogramming-induced cytotoxicity debilitation and systematic immune senescence cascade.

Trogocytosis-orchestrated CLDN18.2-"dressed" CD8+ T cells drive pancreatic cancer progression via glucose metabolic reprogramming-induced cytotoxicity debilitation and systematic immune senescence cascade.

Journal: Gut

Published: May 05, 2025

Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer.

Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer.

Journal: Signal transduction and targeted therapy

Published: April 16, 2025

Development and Prospective Validation of a Cell-free DNA-Based Model for the Early Detection of Pancreatic Cancer.

Development and Prospective Validation of a Cell-free DNA-Based Model for the Early Detection of Pancreatic Cancer.

Journal: Cancer discovery

Published: February 26, 2025

Showing 1-12 of 47

Last Updated: 09/26/2026